Fundraising FoxAbologix
Geneva, CH · 1 known investors
Find your way into Abologix
Sign up to see every warm intro you have to Abologix
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Abologix team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Abologix is a biopharmaceutical company developing two monoclonal antibodies that target JAM-C and Olfactomedin-like protein 3 (Olfml3) for oncology indications. It is a spin-out from the University of Geneva and Geneva University Hospitals.
Founders & leadership
IF
Ignacio FausFounder
BI
Beat ImhofFounder
TM
Thomas MatthesFounder
Investors · 1
Kickfundlisted by KickfundBasel · $950K
How we know: Kickfund's portfolio page · the VCSheet dataset · Not right? Tell us
In the news
Frequently asked questions
- What does Abologix do?
- Abologix is a biopharmaceutical company developing two monoclonal antibodies that target JAM-C and Olfactomedin-like protein 3 (Olfml3) for oncology indications. It is a spin-out from the University of Geneva and Geneva University Hospitals.
- Who founded Abologix?
- Abologix was founded by Ignacio Faus, Beat Imhof, Thomas Matthes.
- Who are Abologix's investors?
- Abologix's investors include Kickfund.
- Where is Abologix headquartered?
- Abologix is headquartered in Geneva, CH.